Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
ORI Capital logo

ORI Capital

Asia, Hong Kong Island, Hong Kong, Wan Chai

Description

ORI Fund is a venture capital fund that invests in innovative companies with disruptive technologies in the global healthcare industry.

Investor Profile

ORI Capital has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 67% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series D rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom.
  • Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.

Stage Focus

  • Series B (44%)
  • Series C (22%)
  • Series D (11%)
  • Series E (11%)
  • Series A (11%)

Country Focus

  • United States (78%)
  • United Kingdom (22%)

Industry Focus

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Oncology
  • Medical Device
  • Medical
  • Therapeutics
  • Life Science
  • Manufacturing
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ORI Capital frequently co-invest with?

PC
Perseverance Capital Management
North America, California, United States, Los Angeles
Co-Investments: 2
4BIO Capital
4BIO Capital
Europe, England, United Kingdom, London
Co-Investments: 1
CincyTech
CincyTech
North America, Ohio, United States, Cincinnati
Co-Investments: 2
Temasek Holdings
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Cintrifuse
Cintrifuse
North America, Ohio, United States, Cincinnati
Co-Investments: 2
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Cowen Group
Cowen Group
North America, New York, United States, New York
Co-Investments: 2
Ohio Innovation Fund
Ohio Innovation Fund
North America, Ohio, United States, Columbus
Co-Investments: 2
Cincinnati Children’s
Cincinnati Children’s
North America, Ohio, United States, Cincinnati
Co-Investments: 2
Partisan Management Group
Partisan Management Group
North America, Colorado, United States, Evergreen
Co-Investments: 2

What are some of recent deals done by ORI Capital?

CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series ENov 15, 2022
Amount Raised: $120,000,000
CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series DDec 10, 2020
Amount Raised: $47,000,000
CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series CMar 18, 2019
Amount Raised: $22,000,000
Enable Injections

Cincinnati, Ohio, United States

Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.

Health CareLife ScienceManufacturingMedical Device
Series BOct 25, 2018
Amount Raised: $50,000,000
Orchard Therapeutics

London, England, United Kingdom

Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BDec 20, 2017
Amount Raised: $110,000,000
Semma Therapeutics

Cambridge, Massachusetts, United States

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 29, 2017
Amount Raised: $114,000,000
Arterys

San Francisco, California, United States

Arterys is a medical imaging platform to deliver clinical AI products over the internet.

Cloud ComputingHealth CareHealth DiagnosticsMedicalMedical Device
Series BNov 15, 2017
Amount Raised: $30,000,000
Kymab

Cambridge, Cambridgeshire, United Kingdom

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics.

BiopharmaBiotechnologyTherapeutics
Series CNov 24, 2016
Amount Raised: $100,000,000
Enable Injections

Cincinnati, Ohio, United States

Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.

Health CareLife ScienceManufacturingMedical Device
Series AOct 5, 2016
Amount Raised: $30,000,000

Find More Investors Like ORI Capital

Discover similar investors in our database and build your perfect investor list.

series_b InvestorsInvestors in Wan ChaiBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors